Although FGF1 may be involved in the pathophysiology of Alzheimer’s disease similar to FGF2, more studies need to be commenced to deduce the exact molecular signaling pathways. This evidence concerns the gene FGF1 and early-onset autosomal dominant Alzheimer disease.